ONE COMMERCE SQUARE, PHILADELPHIA, PA
Termination of Research Collaboration Agreement with Gemma Biotherapeutics
Passage Bio, Inc. Elects Two Directors and Ratifies KPMG Appointment
Restructuring Plan Announced; Workforce Reduction by 75% at Passage Bio
Investor Presentation
Annual Report to Security Holders
Lease Termination Agreement with Hopewell Campus Owner LLC - $4.8 Million Fee
Corporate Presentation Redefining the Course of Neurodegenerative Conditions January 2026
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus Filed Pursuant to Rule 425
S-4
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report